methyl 4-tert-butoxybenzoate | 62370-08-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: methyl 4-tert-butoxybenzoate
• 英文别名: methyl 4-[(2-methylpropan-2-yl)oxy]benzoate
• CAS: 62370-08-5
• 化学式: C₁₂H₁₆O₃
• 分子量: 208.257
• InChiKey: KUFWTSNZJDTHQD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  15
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  methyl 4-tert-butoxybenzoate 在 一水合肼 、 potassium hydroxide 作用下， 以 甲醇 为溶剂， 生成 5-[4-[(2-methylpropan-2-yl)oxy]phenyl]-3H-1,3,4-oxadiazole-2-thione
  参考文献：
  名称：

  Synthesis of piperazinyl benzothiazole/benzoxazole derivatives coupled with 1,3,4-oxadiazole-2-thiol: novel hybrid heterocycles as anticancer agents

  摘要：

  The synthesis of a series of substituted 2-(piperazin-1-yl)benzothiazole/benzoxazole coupled with 1,3,4-oxadiazole-2-thiol pharmacophore (8a-t) is described using a three carbon spacer (Jones and Helm, Drugs 69:1903-1910, 2009). The structures of the compounds were confirmed by NMR and mass spectral data. All the synthesized compounds have been evaluated for their cytotoxicity towards five human cancer cell lines of different origins, viz. MCF-7 (Breast), HeLa (Cervical), HepG(2) (Liver), A431 (Skin) and A549 (Lung), and IC50 values were determined. Among the compounds tested, 8j and 8t displayed maximum cytotoxic activity. A431 was the most sensitive cell line against the compounds studied, followed by MCF7, A549, HepG(2) and HeLa.

  DOI：

  10.1007/s00044-013-0510-y
• 作为产物：
  描述：

  4-碘苯甲酸甲酯 在 1,3,5-三甲氧基苯 、 间氯过氧苯甲酸 、 sodium t-butanolate 作用下， 以 水 、 甲苯 、 乙腈 为溶剂， 反应 4.5h， 生成 methyl 4-tert-butoxybenzoate
  参考文献：
  名称：

  Aryl(TMP)iodonium Tosylate 试剂作为多种芳基中间体的战略切入点：选择性获取芳炔

  摘要：

  芳烃是广泛存在于社会重要分子中的基序。进入不同的芳烃化学空间至关重要，并且非常希望能够从普通试剂中做到这一点。甲苯磺酸芳基（TMP）碘鎓通过多种芳基中间体为芳烃化学空间提供了一个这样的接入点。在这里，我们证明控制反应途径选择性地导致芳烃具有广泛的芳烃和亲芳烃（24 个例子，平均产率 70%）和有效获取生物活性化合物。

  DOI：

  10.1021/acs.orglett.1c01534

文献信息

• HYBRID BLOCK COPOLYMER MICELLES WITH MIXED STEREOCHEMISTRY FOR ENCAPSULATION OF HYDROPHOBIC AGENTS
  申请人：SILL Kevin N.

  公开号：US20080274173A1

  公开（公告）日：2008-11-06

  The present invention relates to the field of polymer chemistry and more particularly to multiblock copolymers and micelles comprising the same.

  本发明涉及聚合物化学领域，更具体地说是涉及多嵌段共聚物以及包含该共聚物的胶束。
• Indirect electrochemical side-chain oxidation of alkyl aromatic compounds - selective synthesis of methyl benzoates or ortho-benzoic acid trimethylesters
  作者：Karl-Heinz Grosse Brinkhaus、Eberhard Steckhan、Dieter Degner

  DOI：10.1016/s0040-4020(01)87454-8

  日期：1986.1

  The technically important side-chain oxidation of alkyl aromatic compounds to from either methyl benzoates or orthobenzoic acid trimethylesters can be performed electrochemically at low potentials in methanol solution using an undivided cell and tris(2,4-dibromopheny1)amine as redox catalyst. Under neutral or slightly acidic conditions methyl benzoates are selectively formed while under basic conditions

  烷基芳族化合物从苯甲酸甲酯或原苯甲酸三甲酯到酯的技术上重要的侧链氧化反应可在甲醇溶液中以低电位通过电化学反应使用三元（2,4-二溴代苯胺）胺作为氧化还原催化剂在低电位下进行。在中性或弱酸性条件下，选择性地生成苯甲酸甲酯，而在碱性条件下，原酸酯占主导。以类似的方式从苯甲醛二甲基乙缩醛选择性地形成邻苯甲酸三甲酯。氧化还原催化剂在反应条件下是稳定的，因此可以进行数千个循环而没有明显的损失。
• Inhibitors of Histone Deacetylase
  申请人：Delorme Daniel

  公开号：US20070213330A1

  公开（公告）日：2007-09-13

  The invention relates to the inhibition of histone deacetylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.

  本发明涉及抑制组蛋白去乙酰化酶的技术。本发明提供了抑制组蛋白去乙酰化酶酶活性的化合物和方法。本发明还提供了治疗细胞增殖性疾病和病况的组合物和方法。
• Imine Compound
  申请人：Saito Shiuji

  公开号：US20080312435A1

  公开（公告）日：2008-12-18

  An imine compound represented by the formula: wherein A represents a heterocyclic group; R 1 , R 2 , an R 3 each represent a hydrogen atom, a halogen atom, a C 1-10 alkyl group optionally substituted with an aryl group(s) substituted with a halogen atom(s), a C 3-10 cycloalkyl group, a C 1-6 haloalkyl group, a C 1-10 alkoxy group, etc.; R 4 represents an optionally substituted C 1-10 alkyl, C 2-6 alkenyl, or aryl group; R 5 represents a hydrogen atom, a C 1-10 alkoxy group, a C 1-6 haloalkyl group, an optionally substituted C 1-10 alkyl or C 2-6 alkenyl group, an optionally substituted aryl or heterocyclic group, etc.; W represents —CO—, —CO—CO—, —CO—NH—, —CS—NH—, or —SO 2 —, or a cannabinoid-receptor agonist comprising said imine compound as an active ingredient. The imine compound of the present invention has a cannabinoid-receptor agonist effect, and is useful as a therapeutic or prophylactic drug for pains and autoimmune diseases.

  一种以以下式表示的亚胺化合物：其中A代表杂环基团；R1、R2和R3分别表示氢原子、卤素原子、C1-10烷基，该烷基可选地取代有芳基，所述芳基取代有卤素原子，C3-10环烷基，C1-6卤代烷基，C1-10烷氧基等；R4表示可选地取代的C1-10烷基，C2-6烯基或芳基；R5表示氢原子，C1-10烷氧基，C1-6卤代烷基，可选地取代的C1-10烷基或C2-6烯基，可选地取代的芳基或杂环基团等；W表示—CO—，—CO—CO—，—CO—NH—，—CS—NH—或—SO2—，或以该亚胺化合物为活性成分的大麻素受体激动剂。本发明的亚胺化合物具有大麻素受体激动剂作用，可用作治疗或预防疼痛和自身免疫性疾病的药物。
• BRIHKHAUS, K. -H. G.;STECKHAN, E.;DEGNER, D., TETRAHEDRON, 1986, 42, N 2, 553-560
  作者：BRIHKHAUS, K. -H. G.、STECKHAN, E.、DEGNER, D.

  DOI：——

  日期：——